EE438 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV LRTD) in the US Birth Cohort
Abstract
Authors
A. Kieffer A. Sardesai R. Musci M. Beuvelet M. Tribaldos Causadias de Su J.K.H. Lee C. Rizzo M. Greenberg